Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women.

Abstract

OBJECTIVE There are limited antiretroviral options for use in the treatment of HIV infection during pregnancy. The purpose of this study was to assess the safety, efficacy and appropriate dosing regimen for ritonavir (RTV)-boosted atazanavir in HIV-1-infected pregnant women. METHODS In this nonrandomized, open-label study, HIV-infected pregnant women were… (More)
DOI: 10.1111/j.1468-1293.2011.00927.x

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.